BridgeMD
New treatment option for Kidney Transplant; Complications
Official title CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
ClinicalTrials.gov ID: NCT07096453
What this study is testing
What is Cytogam?
Cytogam is an investigational medicine, being studied as a potential treatment for kidney transplant; complications.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to study how CMVIG interacts with the body and to see if it might work to prevent kidney transplant patients from becoming infected with CMV.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adult (18-70 year old) kidney transplant recipients
- Patients transitioning from conventional CNI-based immunosuppression to co-stimulatory blockade (belatacept) immunosuppression OR patients who are...
- CMV Ig Seronegative Recipient who received a CMV Ig seropositive Donor
- EBV IgG Positive
You likely can't join if
- Pregnant people
- people unwilling to sign consent and complete follow up visits
- people with IgA immunodeficiency
- people who are receiving IgG therapy or who have received IgG therapy within two months of study enrollment
- Patients who do not speak English and would need a translator and translated consent materials in order to obtain informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.